A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Phase
4Span
260 weeksSponsor
GlaxoSmithKlineCuiaba, Mato Grosso
Recruiting
1-1 of 1